Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$191.17 - $325.63 $515,394 - $877,898
2,696 Added 76.33%
6,228 $2.03 Million
Q4 2023

Jan 26, 2024

BUY
$160.99 - $215.69 $428,555 - $574,166
2,662 Added 305.98%
3,532 $673,000
Q3 2023

Oct 11, 2023

BUY
$194.33 - $283.97 $169,067 - $247,053
870 New
870 $173,000
Q2 2021

Jul 08, 2021

SELL
$131.45 - $201.49 $3,549 - $5,440
-27 Closed
0 $0
Q1 2021

Jun 17, 2021

BUY
$92.73 - $142.05 $2,503 - $3,835
27 New
27 $4,000
Q2 2020

Sep 07, 2021

SELL
$27.25 - $47.53 $17,712 - $30,894
-650 Closed
0 $0
Q1 2020

Sep 07, 2021

BUY
$23.16 - $47.74 $15,054 - $31,031
650 New
650 $21,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.